Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Behav Med. 2016 Jan 18;39(3):429–440. doi: 10.1007/s10865-016-9716-z

Table 4.

Multiple regression analyses of anticipated regret in relation to Health Belief Model variables

Outcome variable Independent variables B R 2 ΔR 2 ΔF p value
Men
 Anticipated regret if unvaccinated and later developed genital warts
  Step 1 <.01 <.01 .13 .72
Have heard of HPV vaccinea .05 .72
  Step 2 .10 .09 4.78 .01
Have heard of HPV vaccinea −.03 .85
Perceived severity of genital warts .24 <.01
Perceived benefits of HPV vaccine against genital warts .12 .10
Perceived risk of genital warts .01 .90
 Anticipated regret if unvaccinated and later developed HPV-related cancer
  Step 1 .01 .01 .94 .34
Have heard of HPV vaccinea .13 .34
  Step 2 .12 .11 5.66 <.01
Have heard of HPV vaccinea .04 .74
Perceived severity of HPV-related cancer .28 <.01
Perceived benefits of HPV vaccine against HPV-related cancer .08 .26
Perceived risk of HPV-related cancer .15 .10
Women
 Anticipated regret if unvaccinated and later developed genital warts
  Step 1 .02 .02 1.97 .17
Have heard of HPV vaccinea .37 .17
  Step 2 .26 .23 8.09 <.01
Have heard of HPV vaccinea .12 .63
Perceived severity of genital warts .40 <.01
Perceived benefits of HPV vaccine against genital warts .23 .02
Perceived risk of genital warts .21 .08
 Anticipated regret if unvaccinated and later developed HPV-related cancer
  Step 1 .02 .02 1.64 .20
Have heard of HPV vaccinea .29 .20
  Step 2 .23 .21 6.77 <.01
Have heard of HPV vaccinea −.21 .40
Perceived severity of HPV-related cancer .58 <.01
Perceived benefits of HPV vaccine against HPV-related cancer .25 .02
Perceived risk of HPV-related cancer −.01 .94

N for men = 143; Ns for women = 80–82; HPV: human papillomavirus. Statistics significant at a p < .05 are denoted in bold. Standardized beta coefficients are presented

a

Have heard of HPV vaccine was coded as 0 = no and 1 = yes